Skip to main content
Erschienen in: European Radiology 10/2013

01.10.2013 | Urogenital

Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration

verfasst von: Olivio F. Donati, Yulia Lakhman, Evis Sala, Irene A. Burger, Hebert A. Vargas, Debra A. Goldman, Vaagn Andikyan, Kay J. Park, Dennis S. Chi, Hedvig Hricak

Erschienen in: European Radiology | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the diagnostic performance of MRI in assessing local tumour extent and evaluate associations between MRI features and survival in patients undergoing MRI before pelvic exenteration for persistent or recurrent gynaecological cancers.

Methods and materials

The study included 50 patients with persistent or recurrent gynaecological malignancies who underwent pelvic exenteration between January 1999 and December 2011 and had MRI at most 90 days before surgery. Two radiologists independently assessed invasion of adjacent organs (on a 5-point scale). Diagnostic accuracy, inter-reader agreement, and associations between organ invasion on MRI and patient survival were evaluated.

Results

Areas under receiver operating characteristic curves (AUCs) for invasion of the bladder, rectum and pelvic sidewall were 0.96, 0.90 and 0.98 for reader 1 and 0.95, 0.88 and 0.90 for reader 2. Corresponding sensitivities/specificities were 87.0 %/92.6 %, 81.3 %/97.0 % and 87.5 %/97.2 % for reader 1, and 87.0 %/100.0 %, 75.0 %/97.0 % and 75.0 %/94.4 % for reader 2. Inter-reader agreement was excellent for organ invasion (κ = 0.81–0.85). Pelvic sidewall invasion on MRI was associated with overall and recurrence-free survival (P = 0.01–0.04 for the two readers).

Conclusion

Preoperative MRI is accurate in predicting organ invasion. It may guide surgical planning and serve as a predictive biomarker in patients undergoing pelvic exenteration for gynaecological malignancies.

Key Points

MRI can accurately assess bladder and rectal wall invasion before major surgery.
MRI identifies patients requiring extended pelvic exenteration by detecting sidewall invasion.
Inter-reader agreement for detecting organ invasion and tumor size is excellent.
Pelvic sidewall invasion on MRI is associated with shorter overall and recurrence-free survival.
Literatur
1.
Zurück zum Zitat Hockel M, Dornhofer N (2006) Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 7:837–847PubMedCrossRef Hockel M, Dornhofer N (2006) Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 7:837–847PubMedCrossRef
2.
Zurück zum Zitat Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1:177–183PubMedCrossRef Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1:177–183PubMedCrossRef
3.
Zurück zum Zitat Andikyan V, Khoury-Collado F, Sonoda Y et al (2012) Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery. Gynecol Oncol 125:404–408PubMedCrossRef Andikyan V, Khoury-Collado F, Sonoda Y et al (2012) Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery. Gynecol Oncol 125:404–408PubMedCrossRef
4.
Zurück zum Zitat Berek JS, Howe C, Lagasse LD, Hacker NF (2005) Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol 99:153–159PubMedCrossRef Berek JS, Howe C, Lagasse LD, Hacker NF (2005) Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol 99:153–159PubMedCrossRef
5.
Zurück zum Zitat Baiocchi G, Guimaraes GC, Rosa Oliveira RA et al (2012) Prognostic factors in pelvic exenteration for gynecological malignancies. Eur J Surg Oncol 38:948–954PubMedCrossRef Baiocchi G, Guimaraes GC, Rosa Oliveira RA et al (2012) Prognostic factors in pelvic exenteration for gynecological malignancies. Eur J Surg Oncol 38:948–954PubMedCrossRef
6.
Zurück zum Zitat Andikyan V, Khoury-Collado F, Gerst SR et al (2012) Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome. Gynecol Oncol 126:346–350PubMedCrossRef Andikyan V, Khoury-Collado F, Gerst SR et al (2012) Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome. Gynecol Oncol 126:346–350PubMedCrossRef
7.
Zurück zum Zitat Houvenaeghel G, Gutowski M, Buttarelli M et al (2009) Modified posterior pelvic exenteration for ovarian cancer. Int J Gynecol Cancer 19:968–973PubMedCrossRef Houvenaeghel G, Gutowski M, Buttarelli M et al (2009) Modified posterior pelvic exenteration for ovarian cancer. Int J Gynecol Cancer 19:968–973PubMedCrossRef
8.
Zurück zum Zitat Ng HT, Kan YY, Ho ES, Yen MS, Chao KC, Yuan CC (1995) Modified pelvic anterior exenteration. Int J Gynaecol Obstet 49:S39–S41PubMedCrossRef Ng HT, Kan YY, Ho ES, Yen MS, Chao KC, Yuan CC (1995) Modified pelvic anterior exenteration. Int J Gynaecol Obstet 49:S39–S41PubMedCrossRef
9.
Zurück zum Zitat Hockel M (2006) Ultra-radical compartmentalized surgery in gynaecological oncology. Eur J Surg Oncol 32:859–865PubMedCrossRef Hockel M (2006) Ultra-radical compartmentalized surgery in gynaecological oncology. Eur J Surg Oncol 32:859–865PubMedCrossRef
10.
Zurück zum Zitat Dowdy SC, Mariani A, Cliby WA et al (2006) Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol 101:280–286PubMedCrossRef Dowdy SC, Mariani A, Cliby WA et al (2006) Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol 101:280–286PubMedCrossRef
11.
Zurück zum Zitat Hockel M, Horn LC, Einenkel J (2012) (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy. Gynecol Oncol. doi:10.1016/j.ygyno.2012.07.120 Hockel M, Horn LC, Einenkel J (2012) (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy. Gynecol Oncol. doi:10.​1016/​j.​ygyno.​2012.​07.​120
12.
Zurück zum Zitat Addley HC, Vargas HA, Moyle PL, Crawford R, Sala E (2010) Pelvic imaging following chemotherapy and radiation therapy for gynecologic malignancies. Radiographics 30:1843–1856PubMedCrossRef Addley HC, Vargas HA, Moyle PL, Crawford R, Sala E (2010) Pelvic imaging following chemotherapy and radiation therapy for gynecologic malignancies. Radiographics 30:1843–1856PubMedCrossRef
13.
Zurück zum Zitat Popovich MJ, Hricak H, Sugimura K, Stern JL (1993) The role of MR imaging in determining surgical eligibility for pelvic exenteration. AJR Am J Roentgenol 160:525–531PubMedCrossRef Popovich MJ, Hricak H, Sugimura K, Stern JL (1993) The role of MR imaging in determining surgical eligibility for pelvic exenteration. AJR Am J Roentgenol 160:525–531PubMedCrossRef
14.
Zurück zum Zitat Kim SH, Han MC (1997) Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging. AJR Am J Roentgenol 168:393–397PubMedCrossRef Kim SH, Han MC (1997) Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging. AJR Am J Roentgenol 168:393–397PubMedCrossRef
15.
Zurück zum Zitat Patel S, Liyanage SH, Sahdev A, Rockall AG, Reznek RH (2010) Imaging of endometrial and cervical cancer. Insights Imaging 1:309–328PubMedCrossRef Patel S, Liyanage SH, Sahdev A, Rockall AG, Reznek RH (2010) Imaging of endometrial and cervical cancer. Insights Imaging 1:309–328PubMedCrossRef
16.
Zurück zum Zitat Forner DM, Meyer A, Lampe B (2010) Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergoing pelvic exenteration. Eur J Obstet Gynecol Reprod Biol 148:182–185PubMedCrossRef Forner DM, Meyer A, Lampe B (2010) Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergoing pelvic exenteration. Eur J Obstet Gynecol Reprod Biol 148:182–185PubMedCrossRef
17.
Zurück zum Zitat Rockall AG, Ghosh S, Alexander-Sefre F et al (2006) Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA? Gynecol Oncol 101:244–249PubMedCrossRef Rockall AG, Ghosh S, Alexander-Sefre F et al (2006) Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA? Gynecol Oncol 101:244–249PubMedCrossRef
18.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
19.
Zurück zum Zitat Sala E, Kataoka M, Pandit-Taskar N et al (2010) Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival. Radiology 257:125–134PubMedCrossRef Sala E, Kataoka M, Pandit-Taskar N et al (2010) Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival. Radiology 257:125–134PubMedCrossRef
20.
Zurück zum Zitat Donaldson SB, Buckley DL, O'Connor JP et al (2010) Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix. Br J Cancer 102:23–26PubMedCrossRef Donaldson SB, Buckley DL, O'Connor JP et al (2010) Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix. Br J Cancer 102:23–26PubMedCrossRef
21.
Zurück zum Zitat Kidd EA, Siegel BA, Dehdashti F, Grigsby PW (2010) Pelvic lymph node F–18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer. Cancer 116:1469–1475PubMedCrossRef Kidd EA, Siegel BA, Dehdashti F, Grigsby PW (2010) Pelvic lymph node F–18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer. Cancer 116:1469–1475PubMedCrossRef
22.
Zurück zum Zitat Husain A, Akhurst T, Larson S, Alektiar K, Barakat RR, Chi DS (2007) A prospective study of the accuracy of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol 106:177–180PubMedCrossRef Husain A, Akhurst T, Larson S, Alektiar K, Barakat RR, Chi DS (2007) A prospective study of the accuracy of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol 106:177–180PubMedCrossRef
23.
Zurück zum Zitat Hawighorst-Knapstein S, Fusshoeller C, Franz C et al (2004) The impact of treatment for genital cancer on quality of life and body image–results of a prospective longitudinal 10-year study. Gynecol Oncol 94:398–403PubMedCrossRef Hawighorst-Knapstein S, Fusshoeller C, Franz C et al (2004) The impact of treatment for genital cancer on quality of life and body image–results of a prospective longitudinal 10-year study. Gynecol Oncol 94:398–403PubMedCrossRef
24.
Zurück zum Zitat Roos EJ, de Graeff A, van Eijkeren MA, Boon TA, Heintz AP (2004) Quality of life after pelvic exenteration. Gynecol Oncol 93:610–614PubMedCrossRef Roos EJ, de Graeff A, van Eijkeren MA, Boon TA, Heintz AP (2004) Quality of life after pelvic exenteration. Gynecol Oncol 93:610–614PubMedCrossRef
25.
Zurück zum Zitat Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM Jr (1989) Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 73:1027–1034PubMedCrossRef Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM Jr (1989) Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 73:1027–1034PubMedCrossRef
26.
Zurück zum Zitat Park JY, Choi HJ, Jeong SY, Chung J, Park JK, Park SY (2007) The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: analysis of risk factors predicting recurrence and survival. J Surg Oncol 96:560–568PubMedCrossRef Park JY, Choi HJ, Jeong SY, Chung J, Park JK, Park SY (2007) The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: analysis of risk factors predicting recurrence and survival. J Surg Oncol 96:560–568PubMedCrossRef
27.
Zurück zum Zitat Grigsby PW, Siegel BA, Dehdashti F (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19:3745–3749PubMed Grigsby PW, Siegel BA, Dehdashti F (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19:3745–3749PubMed
28.
Zurück zum Zitat Tsai CS, Chang TC, Lai CH et al (2004) Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Int J Radiat Oncol Biol Phys 58:1506–1512PubMedCrossRef Tsai CS, Chang TC, Lai CH et al (2004) Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Int J Radiat Oncol Biol Phys 58:1506–1512PubMedCrossRef
Metadaten
Titel
Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration
verfasst von
Olivio F. Donati
Yulia Lakhman
Evis Sala
Irene A. Burger
Hebert A. Vargas
Debra A. Goldman
Vaagn Andikyan
Kay J. Park
Dennis S. Chi
Hedvig Hricak
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 10/2013
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-013-2875-1

Weitere Artikel der Ausgabe 10/2013

European Radiology 10/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.